All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry

DBPR112

CAS number:1226549-49-0    molecular formula:C32H31N5O3

overview

compound introduction

DBPR112 is an orally active furanopyrimidine-based EGFR inhibitor with IC 50 s of 15 nM and 48 nM for EGFR WT and EGFR L858R/T790M , respectively. DBPR112 can occupy the ATP-binding site. DBPR112 has significant antitumor efficacy In Vitro DBPR112 (compound 78; 0.32-1000 nM; 16 hours) induces reduction of phosphorylated EGFR in a dose-dependent manner. DBPR112 shows the inhibitory activity against HCC827 (CC 50 =25 nM), H1975 (CC 50 =620 nM) and A431 Cell (CC 50 =1.02 μM) cell lines. DBPR112 occupies the ATP-binding site and interacts with surrounding residues by covalent bonding, hydrogen bonds, and hydrophobic interactions, which give it a potent inhibitory activity against WT EGFR. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: H1975 cells Concentration: 0.32, 1.6, 8.0, 40, 200, 1000 nM Incubation Time: 16 hours Result: Induced reduction of phosphorylated EGFR in a dose-dependent manner in H1975 cells. In Vivo DBPR112 (orally; 20-50 mg/kg; 5 days/week for 2 consecutive weeks) significantly reduces tumor growth in HCC827 tumor model. DBPR112 (orally; 50 mg/kg; once a day for 15 days) has a significant antitumor effect (mean tumor growth inhibition of 34%) in H1975 tumor model . DBPR112 (IV; 5 mg/kg) has a T 1/2 of 2.3 hours, a CL of 55.6 mL/min•kg, and a V ss of 8.6 L/kg for rats . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: HCC827 tumor model (6- to 8-week-old athymic NU-Fox1nu nude mice) Dosage: 20, 50 mg/kg Administration: Orally; 5 days/week for 2 consecutive weeks (days 1-5 and 8-12) Result: Significantly reduced tumor growth. Animal Model: Rats Dosage: 5 mg/kg for IV and 20 mg/kg for PO (Pharmacokinetic Analysis) Administration: IV or PO Result: Had a T 1/2 of 2.3 hours, a CL of 55.6 mL/min•kg, and a V ss of 8.6 L/kg by IV. Had a T 1/2 of 3.4 hours, a C max of 508 ng/mL and an AUC of 2978 ng/mL•h by PO. Form:Solid IC50& Target:EGFR WT 15 nM (IC 50 ) EGFR L858R/T790M 48 nM (IC 50 )

Specs

Chinese alias-
English alias-
CAS number1226549-49-0molecular formulaC32H31N5O3
molecular weight533.62 g/molExact mass≥98%
PSA104.000 Ųlogp4.900

numbering system

No numbering system information yet

physicochemical properties

No physical and chemical property information yet

Safety information

No safety information yet

Production methods and uses

No production method and use information yet

Related

upstream information

No upstream information yet

downstream information

No downstream information yet

MSDS

Found 0 shareMSDS